Testing an Experimental Coronavirus Vaccine

March 2, 2020

Testing an Experimental Coronavirus Vaccine

An experimental vaccine developed by the National Institute of Allergy and Infectious Diseases (NIAID) and Moderna is ready to enter human testing, announced NIAID director Anthony Fauci. This rapid response, getting a vaccine into phase I trials within three months of the sequencing of the virus, is a new record. Yourway has extensive experience in supporting accelerated clinical trials when the need is acute.

Back to Index

Media

Upcoming Events

Clinical Outsourcing Group (COG)

October 21-22, 2025
Burlingame, California

Schedule a Meeting

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

Media

Articles

Case study: Coordinating a complex intercontinental shipment on a short timeline

Open chat

Hello! How can I help you?